ESBATech ^None

ESBATech is a biopharmaceutical company that was founded in 1998 as a spin out of the University of Zurich. The company is focused on developing fully human antibody fragments for therapeutic applications, with a goal of achieving low risk of systemic drug reactions using topical and local delivery. They use proprietary, fully human single-chain antibody frameworks to generate product candidates against targets of clinical relevance.